De Novo device
KidneyIntelX.dkd
Renalytix Ai, Inc. · Prognostic Test For Assessment Of Chronic Kidney Disease Progression (QWZ, Class II) · First FDA decision Jun 29, 2023, newest Jun 29, 2023DiabetesKidney failure and dialysis
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
Breakthrough-designated
Device trials
0
Naming "KidneyIntelX.dkd"
MAUDE reports
0
Brand "KidneyIntelX.dkd", since 2015
PubMed studies
3
Mentioning "KidneyIntelX.dkd"
AI summary across all sources
Written by Claude (Anthropic's AI) from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- KidneyIntelX.dkdNew device typeBreakthroughDe Novo
DEN200052 · Decided Jun 29, 2023 · 1,037 days after receipt
Device type: Prognostic Test For Assessment Of Chronic Kidney Disease Progression (QWZ) · Laboratory Medicine & Pathology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- KidneyIntelX and KidneyIntelX.dkd TestingLocal determinationIn effectL39726Wellpoint FederalUpdated Jul 14, 2026
- Noninvasive Positive Pressure Ventilation (NIPPV) in the Home for the Treatment of Chronic Respiratory Failure (CRF) Consequent to Chronic Obstructive Pulmonary Disease (COPD)National determinationOn the books240.9Updated Oct 26, 2026
- Serum Iron Studies (Expansion of the Chronic Renal Failure Covered Codes to Include Hypertensive Renal Disease)Coding analysisReview closedCAG-00194NUpdated Sep 15, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "KidneyIntelX.dkd", any status and sponsor, newest update first.
No registered device study names "KidneyIntelX.dkd".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "KidneyIntelX.dkd", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code QWZ
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "KidneyIntelX.dkd"[tiab]. The summary above synthesizes these.
- kidneyintelX.dkd: An Innovation in Precision Medicine for Diabetic Kidney Disease.
Coca SG, Nadkarni GN · J Am Soc Nephrol · 2025
- Derivation and independent validation of kidneyintelX.dkd: A prognostic test for the assessment of diabetic kidney disease progression.
Nadkarni GN, Stapleton S, Takale D, et al. · Diabetes Obes Metab · 2023Research Support, Non-U.S. Gov't
- Baseline Risk and Longitudinal Changes in kidneyintelX.dkd and Its Association With Kidney Outcomes in the CANVAS and CREDENCE Trials.
Moedt E, Coca SG, Edwards K, et al. · Diabetes Care · 2026Randomized Controlled Trial
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.